Market Closed -
OTC Markets
11:09:47 2024-07-01 EDT
|
5-day change
|
1st Jan Change
|
0.0021
USD
|
+5.00%
|
|
+50.00%
|
-8.70%
|
Fiscal Period: März |
2021
|
2022
|
2023
|
2024
|
---|
Capitalization
1 |
3.896
|
18.29
|
4.24
|
0.8313
|
Enterprise Value (EV)
1 |
3.958
|
18.45
|
4.523
|
1.241
|
P/E ratio
|
2,059
x
|
-2.2
x
|
-11
x
|
-5.35
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
18.4
x
|
33.3
x
|
281
x
|
1,212
x
|
EV / Revenue
|
18.7
x
|
33.6
x
|
300
x
|
1,809
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-3,073,272,818
x
|
170,916,597
x
|
-20,738,701
x
|
FCF Yield
|
-
|
-0%
|
0%
|
-0%
|
Price to Book
|
35,000
x
|
-41.6
x
|
-5.12
x
|
-0.84
x
|
Nbr of stocks (in thousands)
|
111,309
|
831,310
|
831,310
|
831,310
|
Reference price
2 |
0.0350
|
0.0220
|
0.005100
|
0.001000
|
Announcement Date
|
21-08-04
|
22-06-29
|
23-06-29
|
24-07-01
|
Fiscal Period: March |
2021
|
2022
|
2023
|
2024
|
---|
Net sales
1 |
0.2115
|
0.5486
|
0.0151
|
0.000686
|
EBITDA
|
-
|
-
|
-
|
-
|
EBIT
1 |
0.0087
|
-0.4341
|
-0.3761
|
-0.1452
|
Operating Margin
|
4.11%
|
-79.14%
|
-2,491.32%
|
-21,171.87%
|
Earnings before Tax (EBT)
1 |
0.0087
|
-0.443
|
-0.3859
|
-0.1562
|
Net income
1 |
0.0087
|
-0.443
|
-0.3859
|
-0.1562
|
Net margin
|
4.11%
|
-80.75%
|
-2,555.82%
|
-22,762.83%
|
EPS
2 |
0.000017
|
-0.0100
|
-0.000464
|
-0.000187
|
Free Cash Flow
|
-
|
-0.006004
|
0.0265
|
-0.0598
|
FCF margin
|
-
|
-1.09%
|
175.27%
|
-8,721.28%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
21-08-04
|
22-06-29
|
23-06-29
|
24-07-01
|
Fiscal Period: March |
2021
|
2022
|
2023
|
2024
|
---|
Net Debt
1 |
0.06
|
0.16
|
0.28
|
0.41
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-0.01
|
0.03
|
-0.06
|
ROE (net income / shareholders' equity)
|
-
|
208%
|
61.4%
|
17.3%
|
ROA (Net income/ Total Assets)
|
-
|
-277%
|
-344%
|
-954%
|
Assets
1 |
-
|
0.1598
|
0.1122
|
0.0164
|
Book Value Per Share
2 |
0
|
-0
|
-0
|
-0
|
Cash Flow per Share
2 |
0
|
0
|
0
|
0
|
Capex
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
Announcement Date
|
21-08-04
|
22-06-29
|
23-06-29
|
24-07-01
|
|
1st Jan change
|
Capi.
|
---|
| -8.70% | 1.75M | | +56.86% | 823B | | +43.90% | 641B | | -6.57% | 352B | | +17.32% | 324B | | +9.94% | 301B | | +16.08% | 241B | | +2.29% | 223B | | +13.96% | 218B | | +7.98% | 167B |
Other Pharmaceuticals
|